FirstString Research Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $26.7M
Latest Deal Amount
  • Investors
  • 6

FirstString Research General Information

Description

Developer of a biopharmaceutical platform intended to treat patients suffering inflammation and injury-based medical conditions. The company's platform offers a drug development process that includes a translation of cell-cell communication and cell-cell adhesion science into a pipeline of drugs and medical applications, enabling health care providers to offer treatment for wound healing and complex tissue regeneration.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Parent Company
Primary Office
  • 300 West Coleman Boulevard
  • Suite 203
  • Mount Pleasant, SC 29464
  • United States
+1 (843) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FirstString Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC 03-Jun-2021 $26.7M 0000 Completed Generating Revenue
16. Later Stage VC (Series C) 26-Mar-2019 000.00 000.00 000.00 Completed Generating Revenue
15. Grant 01-Jan-2019 00.000 000.00 Completed Generating Revenue
14. Later Stage VC (Series B) 05-Jan-2018 0000 000.00 Completed Generating Revenue
13. Later Stage VC 13-Oct-2017 00.000 00.000 000.00 Completed Generating Revenue
12. Merger/Acquisition 27-Jul-2016 00.000 Completed Generating Revenue
11. Grant 26-May-2015 00000 00.000 Completed Generating Revenue
10. Grant 01-Jan-2014 00.000 00.000 Completed Generating Revenue
9. Grant 31-Jan-2013 $300K $7.38M Completed Generating Revenue
8. Grant 18-Jun-2012 $149K $7.38M Completed Generating Revenue
To view FirstString Research’s complete valuation and funding history, request access »

FirstString Research Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series A 12,783,728 $0.001000 $0.08 $1 $1 1x $1 27.39%
To view FirstString Research’s complete cap table history, request access »

FirstString Research Executive Team (8)

Name Title Board Seat Contact Info
Gautam Ghatnekar Ph.D Co-Founder, Chief Executive Officer, President and Board Member
Curtis Mo Executive Officer
Robert Gourdie Ph.D Co-Founder and Scientific Advisor
Christina Grek Ph.D Senior Director, Research & Development
John Waymack MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

FirstString Research Board Members (12)

Name Representing Role Since
D. Carwile JD Self Board Member 000 0000
David Leffell MD Self Board Member 000 0000
Elliot Favus MD Self Board Member 000 0000
Neal McConnell Self Board Member 000 0000
Tina Nova Ph.D Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

FirstString Research Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FirstString Research Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cato BioVentures Corporate Venture Capital Minority 000 0000 000000 0
Charleston Angel Partners Angel Group Minority 000 0000 000000 0
To view FirstString Research’s complete investors history, request access »